Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
![Medchemexpress LLC 1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]propyl]tetrahydro-](https://assets.fishersci.com/TFS-Assets/CCG/product-images/default.jpg-650.jpg)
Medchemexpress LLC 1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]propyl]tetrahydro- | 2543673-19-2 | 99.7% | 535.60 | 500 MG
Supplier: Medchemexpress LLC HY160699500MG
DCC-3116 is an orally active ULK1/2 inhibitor. It inhibits autophagy in lung cancer cells by targeting KRASG12C signaling, which in turn inhibits the proliferation of lung cancer cells and exhibits anti-cancer effects.
- Orally active ULK1/2 inhibitor.
- Inhibits autophagy in lung cancer cells.
- Inhibits KRASG12C signaling.
- Exerts anti-cancer effects.
- Available in various quantities.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?